FDA
approval
· 2025-12-04
FDA Approved: TOPIRAMATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
The FDA approved Glenmark Pharmaceuticals' supplemental application for Topiramate, enabling a generic version of this anticonvulsant. The action confirms regul…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TOPIRAMATE (TOPIRAMATE)